Novel antitumoral use of cabazitaxel

Details for Australian Patent Application No. 2010310986 (hide)

Owner Aventis Pharma S.A.

Inventors Gupta, Sunil

Agent A J Park

Pub. Number AU-A-2010310986

PCT Pub. Number WO2011/051894

Priority 61/256,160 29.10.09 US; 61/369,929 02.08.10 US; 61/355,834 17.06.10 US; 61/355,888 17.06.10 US; 61/383,933 17.09.10 US; 61/293,903 11.01.10 US; 61/389,969 05.10.10 US

Filing date 27 October 2010

Wipo publication date 5 May 2011

International Classifications

A61K 31/164 (2006.01) - of a carboxylic acid with an aminoalcohol, e.g. ceramides

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/051894 Priority application(s): WO2011/051894

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310994-Conversion of carbon containing feedstock

2010310985-Modified meningococcal fHBP polypeptides